India proposes BRICS consortium to tackle post-COVID challenges, NCDs as flagship programme
From the Indian side, key scientific institutions that participated include the DST, Department of Biotechnology (DBT), Indian Institute of Technology Delhi, All India Institute of Medical Sciences-New Delhi, Indian Institute of Technology Jodhpur, the Banaras Hindu University and the Delhi University.;
New Delhi: India has proposed a BRICS consortium to address post-Covid challenges and tackling non-communicable diseases as a flagship programme during a meeting of scientists, officials and academicians from the countries in the bloc, the Department of Science and Technology said Thursday.
The members of the working group on Biotechnology and Biomedicine suggested future directions of research collaboration among BRICS countries in the areas such as antimicrobial resistance, long post-Covid challenges, complications including molecular pathogenesis of coronavirus, artificial intelligence, digital health medicine, non-communicable diseases and cancer among others.
Also Read: Researchers report stroke in young adults after COVID-19 vaccination
The five BRICS countries -- Brazil, Russia, India, China, and South Africa -- shared their experiences in fighting Covid-19 and their pandemic preparedness.
They presented their current work, their interests in joint funding areas, including opportunities for collaboration with other countries in the grouping, their strengths, milestones and achievements in the field of Biotechnology and Biomedicine, the DST said.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.